NAFLD was associated with male sex; older age; body mass index (BMI) of 30 kg/m2 or more; homeostatic model assessment of insulin resistance (HOMA-IR) of more than 2.15; diabetes mellitus; cardiopathy; dyslipidemia; metabolic syndrome; higher waist circumference, levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), LDL-cholesterol, triglycerides, erythrocyte sedimentation rate (ERS), and high-sensitivity C-reactive protein (hs-CRP); and non-viable bacterial translocation (BT). The gene discussed is MAP3K14; the disease is metabolic dysfunction-associated steatotic liver disease.